DIVI S LABORATORIES LTD Valuation
DIVISLAB · Healthcare · Current price ₹7,247.5
Is DIVI S LABORATORIES LTD undervalued?
DocStoX estimates the fair value of DIVI S LABORATORIES LTD at ₹1,561 per share, versus the current market price of ₹7,248. That puts the stock about -78.5% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹770), Relative P/E (₹3,358), Graham floor (₹1,172). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹770 (bear) to ₹1,561 (base) to ₹3,358 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
DIVI S LABORATORIES LTD trades at a P/E of 74.9x and a P/B of 10.7x, with a dividend yield of 0.4%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on DIVI S LABORATORIES LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.